glycerophosphoinositol 4,5-bisphosphate has been researched along with Coxsackie Virus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Fang, C; Ge, B; Leng, Q; Li, H; Liu, F; Lu, H; Shen, L; Sun, J; Sun, L; Wang, F; Wang, L; Wu, D; Wu, J; Xu, A; Yan, D; Yang, C; Yang, J; Zhang, Q; Zhou, Y | 1 |
1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Coxsackie Virus Infections
Article | Year |
---|---|
PLCĪ²2 negatively regulates the inflammatory response to virus infection by inhibiting phosphoinositide-mediated activation of TAK1.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Coxsackievirus Infections; Cytokines; Enterovirus; Enzyme Activation; Gene Expression Regulation; HEK293 Cells; Humans; MAP Kinase Kinase Kinases; Mice, Inbred C57BL; Mice, Knockout; Phosphatidylinositol 4,5-Diphosphate; Phospholipase C beta; Protein Binding; Vero Cells | 2019 |